MentionFox
Home › funding signals › MultiValent Biotherapies, Inc.
Company · SEC filings

MultiValent Biotherapies, Inc. funding history

MultiValent Biotherapies, Inc. has 2 Form D filings on record, from 2026-02-27 to 2026-03-02. Together its new offerings report $10.02M sold.

Funding historyFounders and team

What do you want to do with MultiValent Biotherapies, Inc.?

Based
LOS ALTOS, CALIFORNIA
Year formed
2025
Industry group
Biotechnology
Filings
2
Raised (new offerings)
$10.02M

Every filing

FiledTypeAmount soldTotal offeringRecords
2026-03-02New offering
first sale 2026-01-09
$10.01M—details · SEC filing
2026-02-27New offering
first sale 2026-01-05
$4K$4KSEC filing

How the total is counted: the amount sold on each new offering, added together. Amendments are left out, because an amendment restates an offering already counted. A filing whose figures have not been read yet shows a dash and adds nothing.

Every figure here is read from MultiValent Biotherapies, Inc.'s own filings with the SEC. The people those filings name are on the team page.

Cite this page

Permanent URL: https://mentionfox.com/company/multivalent-biotherapies-inc
Last updated 2026-09-26
Primary record: SEC filing 1 · SEC filing 2
MultiValent Biotherapies, Inc. funding history: 2 SEC filings, $10.02M raised. MentionFox, 2026-09-26. https://mentionfox.com/company/multivalent-biotherapies-inc